CN102824576B - Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof - Google Patents
Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof Download PDFInfo
- Publication number
- CN102824576B CN102824576B CN 201110160046 CN201110160046A CN102824576B CN 102824576 B CN102824576 B CN 102824576B CN 201110160046 CN201110160046 CN 201110160046 CN 201110160046 A CN201110160046 A CN 201110160046A CN 102824576 B CN102824576 B CN 102824576B
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- preparation
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 201000004681 Psoriasis Diseases 0.000 title abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 38
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 239000002775 capsule Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 8
- 238000007796 conventional method Methods 0.000 claims abstract description 4
- 239000006187 pill Substances 0.000 claims abstract description 3
- 241000222640 Polyporus Species 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 238000011282 treatment Methods 0.000 abstract description 14
- 208000002193 Pain Diseases 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 241000758794 Asarum Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000007232 Illicium verum Species 0.000 abstract 1
- 235000008227 Illicium verum Nutrition 0.000 abstract 1
- 244000171085 Polyporus umbellatus Species 0.000 abstract 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 206010040882 skin lesion Diseases 0.000 description 10
- 231100000444 skin lesion Toxicity 0.000 description 10
- 206010037888 Rash pustular Diseases 0.000 description 9
- 208000029561 pustule Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 208000036487 Arthropathies Diseases 0.000 description 4
- 208000012659 Joint disease Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000207929 Scutellaria Species 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000002310 elbow joint Anatomy 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000036473 myasthenia Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- JGQGCJKPBAYEHO-UHFFFAOYSA-N 1-(morpholin-4-ylmethyl)-4-[2-[4-(morpholin-4-ylmethyl)-3,5-dioxopiperazin-1-yl]ethyl]piperazine-2,6-dione Chemical compound C1C(=O)N(CN2CCOCC2)C(=O)CN1CCN(CC1=O)CC(=O)N1CN1CCOCC1 JGQGCJKPBAYEHO-UHFFFAOYSA-N 0.000 description 1
- GBLIGNUYGOFIKS-UHFFFAOYSA-N 4-[2-(3,5-dioxopiperazin-1-yl)ethyl]piperazine-2,6-dione Chemical compound C1C(=O)NC(=O)CN1CCN1CC(=O)NC(=O)C1 GBLIGNUYGOFIKS-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010015278 Erythrodermic psoriasis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 208000014267 psoriasis 8 Diseases 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal composition for treating psoriasis and a preparation method thereof. The composition comprises the following drug materials of: by weight, 20-30 parts of Smilax glabra, 15-20 parts of root of large-flowered skullcap, 20-25 parts of Asarum Herb, 15-20 parts of coptis, 10-15 parts of rheum officinale, 5-10 parts of star anise, 20-25 parts of Polyporus umbellatus and 15-20 parts of licorice. According to the preparation method, the above drug materials are weighed; each ingredient is crushed into a powder of 80-120 meshes; then the powders are uniformly mixed and are made into capsules, pills or powders according to a conventional method. The traditional Chinese medicinal composition provided by the invention has effects of adjusting human balance, eliminating siltation, removing blood stasis, expelling wind and dissipating cold, stopping endogenous wind, alleviating convulsion, relaxing vein and relieving pain, and has advantages of short treatment course and definite therapeutic effects. Cure rate of the composition for common psoriasis reaches up to 85.3%, and its total effective rate reaches 100%.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of psoriasic Chinese medicine composition and preparation method thereof for the treatment of.
Background technology
" psoriasis " belongs to commonly encountered diseases, frequently-occurring disease, the distribution position is different, state of an illness weight difference is very large, psoriasic type generally can be divided into multiple, modal is the homeliness type psoriasis, show as erythra and generally occur in scalp, trunk and extremity, occur red pimple on skin, expansion is fused into patch or speckle gradually, there are thicker silvery white phosphorus bits on the surface, out-of-shape, some skin lesion are more, are starlike over the sky, the squama pull-up falls behind, wipe gently scurf off and can see the red film of one deck, strike off red film and can see little petechia, medically make again the sieve shape hemorrhage.Other psoriasis type is just like pustule type psoriasis, psoriasis arthropathica, erythrodermic psoriasis etc., and these also happen occasionally, but are not too common.
It is multiple that psoriasic pathogenic factor mainly contains heredity, immunologic function disorder, direct stimulation, trauma infection contamination etc. at present, but there is no so far clearly final conclusion.Clinically mainly with cell toxicant kind anti-cancer drugs such as aminopterin, ethyliminum, bimolane, cyclophosphamide, and the hormone medicines treatments such as dexamethasone, prednisone, betamethasone and import injection, triamcinolone.The various preparations of above medicine and preparation thereof though with afterwards short run effect being arranged, control rear easy recurrence, often are difficult to thorough healing.How to allow the psoriatic break away from the puzzlement of the serious illness, make the thorough rehabilitation of patient, be the problem that medical circle is paid close attention to always.
Summary of the invention
The object of the present invention is to provide a kind of psoriasic Chinese medicine composition for the treatment of, utilize said composition treatment psoriasis short treating period, determined curative effect is with rear difficult recurrence.
The technical scheme that the present invention takes: a kind ofly treat psoriasic Chinese medicine composition, raw material medicaments in part by weight is: Rhizoma Smilacis Glabrae 20-30 part, Radix Scutellariae 15-20 part, Herba Asari 20-25 part, Rhizoma Coptidis 15-20 part, Radix Et Rhizoma Rhei 10-15 part, anistree 5-10 part, Polyporus 20-25 part, Radix Glycyrrhizae 15-20 part.
In described Chinese medicine composition, Rhizoma Smilacis Glabrae 24 grams, Radix Scutellariae 18 grams, Herba Asari 20 grams, Rhizoma Coptidis 18 grams, Radix Et Rhizoma Rhei 12 grams, anistree 6 grams, Polyporus 21 grams, Radix Glycyrrhizae 18 grams.
The preparation method of described Chinese medicine composition takes each crude drug, and each component is ground into 80～120 purpose powder, and then mix homogeneously, make capsule, pill or powder according to a conventional method.
Pharmacology analysis:The present invention is that the inventor is according to oneself clinical experience for many years, get in conjunction with motherland's Chinese medicine marrow dialectical prescription, because psoriasis is damp and hot attacking due to the skin, the present invention is take heat-clearing and toxic substances removing, the cold expelling that induces sweat, expelling wind and removing dampness, reducing swelling and alleviating pain as purpose, adjust total balance of the body, eliminate alluvial, improve total balance of the body, improve skin functional recovery ability, utilize the mutual synergism between medicine, control psoriasic expansion and spread, reaching the effect for the treatment of both the principal and secondary aspects of a disease, reaching at last the purpose of radical cure.
In crude drug, Rhizoma Smilacis Glabrae: the property slightly sweet flavor is flat; Return liver, stomach warp, detoxifcation, dehumidifying, sharp joint; Control syphilis, stranguria with turbid discharge, muscles and bones spasm and pain, beriberi, furuncle, carbuncle, scrofula.Radix Scutellariae: nature and flavor are bitter, and are cold, return lung, gallbladder, spleen, large intestine, small intestine meridian; Cure mainly heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive; Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, the cough due to lung-heat, high hot excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.Herba Asari: nature and flavor are hot, warm; Return lung, kidney channel, cure mainly and dispel the wind, cold expelling, row water is had one's ideas straightened out; Control air-cooled headache, nasal sinusitis, toothache, phlegm retention cough with dyspnea, rheumatic arthralgia.Rhizoma Coptidis: nature and flavor are bitter, cold; GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel; Heat clearing and damp drying, eliminating fire and detoxication; Be used for cold and heat and tie mutually, damp and hot middle resistance, feeling of fullness vomiting.Radix Et Rhizoma Rhei: nature and flavor are bitter, cold; Return spleen, stomach, large intestine, liver, pericardium channel; Cure mainly purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation; Be used for the excess-heat constipation, stagnant stomachache, dysentery is not well, jaundice due to damp-heat, heat in blood is told nosebleed, conjunctival congestion, pharyngeal swelling, abdominalgia with intestinal abscess, carbuncle furuncle, blood stasis amenorrhea, traumatic injury, external treatment burn due to hot liquid or fire; Upper gastrointestinal hemorrhage.Anistree: nature and flavor are hot, and are sweet, temperature; Be included into spleen, kidney channel; Warming YANG, cold expelling is regulated the flow of vital energy, sterilization; Control the invasion by pathogenic cold vomiting, colic of cold type stomachache, lumbago due to renal deficiency, dried, beriberi caused by pathogenic damp.Polyporus: the property slightly sweet flavor is flat; Return spleen, kidney, urinary bladder channel; Dysuria is controlled in the diuresis eliminating dampness by diuresis, the edema distension, and beriberi is had loose bowels, pouring, turbid, leukorrhagia.Radix Glycyrrhizae: nature and flavor are sweet, and are flat; Be included into spleen, stomach, lung meridian; With middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.
Using method: Chinese medicine composition of the present invention is made capsule, and 3 times on the one, each 2,2 months is a course for the treatment of, and every capsules contains effective composition 0.3g, and other dosage forms can be taken with reference to this dosage.
Positive beneficial effect of the present invention:
(1) Chinese medicine composition of the present invention is on the basis of secret prescription handed down in the family from generation to generation, inheriting tradition medical science elite, in conjunction with character of traditional Chinese medicine and pathogeny, screen by research for many years, have an adjustment total balance of the body, eliminate alluvial, the effect of removing blood stasis eliminating stagnation, expelling wind and cold, relieving spasm by subduing liver-wind, removing obstruction in the collateral to relieve pain, curing psoriasis is had advantages of short treating period, determined curative effect, and up to 85.3%, total effective rate reaches 100% to common psoriasic cure rate.
(2) curative effect of medication of the present invention is lasting, and short treating period, instant effect are difficult for recurrence after curing, and has changed in the past that medicine is difficult to effect a radical cure this sick difficult problem, and method for making is simple, is worth applying clinically.
(3) drug use safety of the present invention, without any side effects, cost is low, and is easy to use, and the patient spends few, has greatly reduced patient's financial burden.
The curative effect statistics:In recent years in 278 routine patients for the treatment of, male 158 examples wherein, female's 120 examples, age distribution is at 20 ~ 75 years old, and between the course of disease 1 year-15 years, the overwhelming majority is the homeliness type psoriasis, accounts for 246 examples.In 278 routine patients, the case of fully recovering through treatment is 237 examples, accounts for 85.3%; The produce effects case is 19 examples, accounts for 6.8%, and the improvement case is 22 examples, accounts for 7.9%, total effective rate 100%.
Efficacy assessment standard:
Recovery from illness: the skin lesion symptoms such as red pimple and speckle, squamous silver bits, shinny thin film, petechial hemorrhage, pustule all disappear, the arthropathy of getting involved, pain disappearance, activity freely, other conscious Signs all disappears.
Produce effects: the skin lesion symptoms such as red pimple, squamous silver bits, shinny thin film, petechial hemorrhage, pustule etc. obviously disappear more than 70%, and the arthropathy of getting involved returns to normally substantially, and pain obviously alleviates, and mobility significantly strengthens, and other conscious Signs obviously disappears.
Take a turn for the better: the skin lesion resolution of symptoms such as red pimple, silver bits, shinny thin film, petechial hemorrhage, pustule are more than 50%, and the arthropathy of getting involved, pain alleviate to some extent, can do the activity of bending and stretching by a small margin, and other conscious Signs alleviates to some extent.
Invalid: the skin lesion symptoms such as red pimple, silver bits, shinny thin film, petechial hemorrhage, pustule are without obviously disappearing, and the arthropathy of getting involved, pain are unchanged, and activity is still limited, and other conscious Signs is unchanged.
Model case:
Case 1: Lee so-and-so, man, 55 years old.Examine in April, 2005, readme before 4 years extremity, trunk play tinea, the surface has silvery white phosphorus bits to come off, out-of-shape, the red pruritus of color, striking off red film has little petechia.Be diagnosed as the homeliness type psoriasis.Take the capsule of embodiment 1, treat after 3 months, whole body silvery white phosphorus bits disappear, pruritus no longer, and skin smooth, recovery from illness, after treatment 1 month again, follow up a case by regular visits to so far recurrence subsequently.
Case 2: Zhu, man, 65 years old.In JIUYUE, 2006 is examined, and readme got psoriasis 8 years, began oneself and paid no attention to, occur red pimple on extremity skin, there are thicker silvery white phosphorus bits, out-of-shape in the surface, skin lesion is more, is starlike over the sky, and squama pull-up backwardness can be seen the red film of one deck, strike off red diaphragm screen shape petechia, but psoriasis has the sign that increases the weight of recently, pruritus is abnormal, myasthenia of limbs, helplessly, turn to any doctor one can find when critically ill, have the attitude of trying in arms and come the inventor to locate to seek to wish.Be diagnosed as the homeliness type psoriasis.Take the capsule of embodiment 2, after treatment February, pruritus alleviates, and white phosphorus bits reduce, and continue medication two months, and white phosphorus bits disappear, skin smooth, and recovery from illness, after treatment 1 month again, follow up a case by regular visits to so far recurrence subsequently.
Case 3: Xue, female, 70 years old.Examine in July, 2009, before readme 7 years, originally only have scalp and the proriasiform skin lesion of elbow joint position appearance, since nearest 1 year, the symptom of pain appears in elbow joint, multi-treatment poor effect once, the arthralgia phenomenon is gradually serious, joint stuffiness, myasthenia of limbs, helplessly, having the attitude of trying in arms comes the inventor to locate to seek to wish.After diagnosing, be diagnosed as " arthropathica psoriasis ", take the capsule of embodiment 3, after 30 days, the skin lesion symptom comes off gradually, and arthralgia makes moderate progress, and can do some flexors by a small margin; Continued again medication 30 days, the skin lesion position returns to the normal colour of skin substantially fully, and the arthralgia symptom disappears, activity freely, rear use was consolidated medication 30 days, the recurrence of following up a case by regular visits to that so far there are no.
Case 4: Zhang, female, 38 years old.In February, 2010, readme skin lesion onset is on the basis of acute inflammation erythema, most intensive syringe needles occur to the shallow pustule of foxtail millet grain size aseptic table, with a small amount of thin thin squama, after scurf comes off, has abscess to occur; Closely over the past half year, pustule increases rapidly, mutually is fused into large stretch of pus pasty state, with high heat, arthralgia and general malaise, be diagnosed as " pustule type psoriasis ", take the capsule of embodiment 4 after 2 months, pustule begins incrustation, most of squama comes off, continue medication 2 months, incrustation speckle and squama disappear, and skin recovers normal color, rear use was consolidated medication 30 days, the recurrence of following up a case by regular visits to that so far there are no.
The specific embodiment
Following examples are detailed description of the invention, are not any limitation of the invention.
Example 1: a kind ofly treat psoriasic Chinese medicine composition, raw material medicaments in part by weight is: Rhizoma Smilacis Glabrae 24 grams wherein, Radix Scutellariae 18 grams, Herba Asari 20 grams, Rhizoma Coptidis 18 grams, Radix Et Rhizoma Rhei 12 grams, anistree 6 grams, Polyporus 21 grams, Radix Glycyrrhizae 18 grams.
Preparation method: take each crude drug, each component is ground into 80～120 purpose powder, then mix homogeneously, make capsule according to a conventional method, and every contains effective composition 0.3 gram.
Example 2: basic identical with example 1, difference is:
Crude drug forms: 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Radix Scutellariaes, 20 parts of Herba Asaris, 15 parts of Rhizoma Coptidis, 10 parts of Radix Et Rhizoma Rhei, anistree 5 parts, 20 parts of Polyporus, 15 parts, Radix Glycyrrhizae.
Example 3: basic identical with example 1, difference is:
Crude drug forms: 30 parts of Rhizoma Smilacis Glabraes, 20 parts of Radix Scutellariaes, 25 parts of Herba Asaris, 20 parts of Rhizoma Coptidis, 15 parts of Radix Et Rhizoma Rhei, anistree 10 parts, 25 parts of Polyporus, 20 parts, Radix Glycyrrhizae.
Example 4: basic identical with example 1, difference is:
Crude drug forms: 25 parts of Rhizoma Smilacis Glabraes, 18 parts of Radix Scutellariaes, 22 parts of Herba Asaris, 16 parts of Rhizoma Coptidis, 12 parts of Radix Et Rhizoma Rhei, anistree 8 parts, 22 parts of Polyporus, 18 parts, Radix Glycyrrhizae.
Example 5: basic identical with example 1, difference is:
Crude drug forms: 28 parts of Rhizoma Smilacis Glabraes, 17 parts of Radix Scutellariaes, 22 parts of Herba Asaris, 18 parts of Rhizoma Coptidis, 12 parts of Radix Et Rhizoma Rhei, anistree 6 parts, 21 parts of Polyporus, 17 parts, Radix Glycyrrhizae.
Claims (3)
1. treat psoriasic Chinese medicine composition for one kind, it is characterized in that: raw material medicaments in part by weight is: Rhizoma Smilacis Glabrae 20-30 part, Radix Scutellariae 15-20 part, Herba Asari 20-25 part, Rhizoma Coptidis 15-20 part, Radix Et Rhizoma Rhei 10-15 part, anistree 5-10 part, Polyporus 20-25 part, Radix Glycyrrhizae 15-20 part.
2. Chinese medicine composition claimed in claim 1 is characterized in that: Rhizoma Smilacis Glabrae 24 grams wherein, Radix Scutellariae 18 grams, Herba Asari 20 grams, Rhizoma Coptidis 18 grams, Radix Et Rhizoma Rhei 12 grams, anistree 6 grams, Polyporus 21 grams, Radix Glycyrrhizae 18 grams.
3. the preparation method of the described Chinese medicine composition of claim 1, it is characterized in that: take each crude drug, each component is ground into 80～120 purpose powder, then mix homogeneously, make capsule, pill or powder according to a conventional method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110160046 CN102824576B (en) | 2011-06-15 | 2011-06-15 | Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110160046 CN102824576B (en) | 2011-06-15 | 2011-06-15 | Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102824576A CN102824576A (en) | 2012-12-19 |
| CN102824576B true CN102824576B (en) | 2013-11-06 |
Family
ID=47328022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110160046 Expired - Fee Related CN102824576B (en) | 2011-06-15 | 2011-06-15 | Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102824576B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362440A (en) * | 2015-12-10 | 2016-03-02 | 隋妍蕾 | Chinese and Western medicine compound composition for treating scalp infection and preparation method of composition |
| CN108403920A (en) * | 2018-05-31 | 2018-08-17 | 段洪明 | Chinese medicine composition and the preparation method and application thereof for treating skin disease of bursting from head to foot |
| CN111840500A (en) * | 2019-04-10 | 2020-10-30 | 王旻霞 | Traditional Chinese medicine composition for treating psoriasis vulgaris |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214261A (en) * | 1998-10-21 | 1999-04-21 | 余际康 | Oral medicine for curing dermatosis |
| CN1242201A (en) * | 1998-07-20 | 2000-01-26 | 徐景信 | Patent traditional Chinese medicine for treating psoriasis, and method for preparing same |
-
2011
- 2011-06-15 CN CN 201110160046 patent/CN102824576B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1242201A (en) * | 1998-07-20 | 2000-01-26 | 徐景信 | Patent traditional Chinese medicine for treating psoriasis, and method for preparing same |
| CN1214261A (en) * | 1998-10-21 | 1999-04-21 | 余际康 | Oral medicine for curing dermatosis |
Non-Patent Citations (6)
| Title |
|---|
| 中医药治疗银屑病概述;施晓红;《山西中医》;19980430;第14卷(第2期);37-39 * |
| 中药"银屑片"治疗牛皮癣;王佐春;《中医杂志》;19841231(第10期);28 * |
| 施晓红.中医药治疗银屑病概述.《山西中医》.1998,第14卷(第2期),37-39. |
| 王佐春.中药"银屑片"治疗牛皮癣.《中医杂志》.1984,(第10期),28. |
| 谈增福.银屑病证治十二法.《皮肤病与性病》.1996,第18卷(第4期),34-35. |
| 银屑病证治十二法;谈增福;《皮肤病与性病》;19961231;第18卷(第4期);34-35 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102824576A (en) | 2012-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103656027A (en) | External-application plaster for treating hyperosteogeny | |
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN103463297A (en) | Traditional Chinese medicine composition for treating eczema of scrotum as well as preparation method and use thereof | |
| CN106236854A (en) | The Chinese medicine composition of a kind for the treatment of of arthritis and application thereof | |
| CN102824576B (en) | Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof | |
| CN104353019A (en) | Traditional Chinese medicine hot compress bag with meridian dredging and internal organ conditioning functions and preparation method of traditional Chinese medicine hot compress bag | |
| CN105079188A (en) | Traditional Chinese medicine composition for treating anaphylactoid purpura | |
| CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
| CN104147194B (en) | Traditional Chinese medicine composition for treating chronic sinusitis | |
| CN103830657A (en) | Medicine for treating chronic cholecystitis | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
| CN104971331A (en) | Orally-taken externally-applied traditional Chinese medicine composition for treating proliferation of mammary gland and preparation method | |
| CN104399055A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN103007063A (en) | Medicinal composition for treating facial paralysis and preparation method thereof | |
| CN103585273B (en) | Traditional Chinese medicine composition for treating local swelling and pain | |
| CN101797291B (en) | Traditional Chinese medicine for treating osteoproliferation | |
| CN102028768B (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN104474405A (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN102824450B (en) | Externally-applied medicine for treating psoriasis and preparation method thereof | |
| CN103041362A (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN102579613A (en) | Oral Chinese medicinal composition for treating rheumatism pain | |
| CN100450537C (en) | Chinese medicinal formulation for treating prostate hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Xiru Inventor after: Wang Haibin Inventor before: Wang Haibin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG HAIBIN TO: ZHANG XIRU WANG HAIBIN |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 Termination date: 20160615 |